CN109470873A - Method of immunity, the system for identifying immunoassays and kit - Google Patents

Method of immunity, the system for identifying immunoassays and kit Download PDF

Info

Publication number
CN109470873A
CN109470873A CN201811401320.2A CN201811401320A CN109470873A CN 109470873 A CN109470873 A CN 109470873A CN 201811401320 A CN201811401320 A CN 201811401320A CN 109470873 A CN109470873 A CN 109470873A
Authority
CN
China
Prior art keywords
sample
subunit
amplification
human chorionic
tested
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811401320.2A
Other languages
Chinese (zh)
Other versions
CN109470873B (en
Inventor
杨阳
赵卫国
张向辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boyang Biotechnology (Shanghai) Co Ltd
Original Assignee
Boyang Biotechnology (Shanghai) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boyang Biotechnology (Shanghai) Co Ltd filed Critical Boyang Biotechnology (Shanghai) Co Ltd
Priority to CN201811401320.2A priority Critical patent/CN109470873B/en
Publication of CN109470873A publication Critical patent/CN109470873A/en
Application granted granted Critical
Publication of CN109470873B publication Critical patent/CN109470873B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The present invention relates to a kind of human chorionic gonadotropin's gland of light-induced chemiluminescent technical field swash and β subunit method of immunity, it is a kind of for surveyor's chorionic gonadotrophin swash and the immunoassays of β subunit system and it is a kind of detection human chorionic gonadotropin's gland swash and β subunit kit；And another human chorionic gonadotropin's gland swashs and the method for immunity of β subunit, another swashs for surveyor's chorionic gonadotrophin and the system of β subunit immunoassays and another detection human chorionic gonadotropin's gland swashs and the kit of β subunit.

Description

Method of immunity, the system for identifying immunoassays and kit
It is on November 22nd, 2016 that the application, which is the applying date, entitled " immune application No. is 201611026623.1 The divisional application of the Chinese patent application of measuring method, the system for identifying immunoassays and kit ".
Technical field
The present invention relates to light-induced chemiluminescent technical fields, and in particular to a kind of human chorionic gonadotropin's gland swashs and β subunit Method of immunity, it is a kind of for surveyor's chorionic gonadotrophin swash and the immunoassays of β subunit system and a kind of detection Human chorionic gonadotropin's gland swashs and the kit of β subunit；And another human chorionic gonadotropin's gland swashs and the immune survey of β subunit Determine method, another swash for surveyor's chorionic gonadotrophin and the system of β subunit immunoassays and another detection people's suede Chorionic gonadotropin gland swashs and the kit of β subunit.
Background technique
Immunology detection be based on antigen and antibody specific reaction principle carry out, due to its can use isotope, Enzyme, chemiluminescent substance etc. carry out display or the amplification of signal to measured object, therefore are commonly used for detecting protein, hormone etc. micro- Measure bioactive substance.
Chemiluminescence immune assay is then to develop relatively rapid on-radiation immunoassay technology in recent years, and principle is benefit The amplification of signal is carried out with chemiluminescent substance, and by its luminous intensity, immune cohesive process is directly measured, the method Have become one of the important directions of immunology detection.
Light-induced chemiluminescent method is one of common method of chemiluminescence analytical technique, and it is intermolecular to can be used for studying biology Interaction, is clinically mainly used for the detection of disease.The technology incorporates high molecular particle technology, organic synthesis, protein The research of the related fieldss such as chemistry and clinical detection.It is combined in a certain range by photosensitive particulate and luminous particle, is generated The transmitting of ion oxygen energy issues optical signal, to detect to sample to be tested.Wherein, thoughts are filled inside photosensitive particulate Optical compounds, and luminophor and lanthanide series are filled with inside luminous particle.In swashing for red laser (600~700nm) It gives, photosensitive particulate releases the singlet oxygen ion (4 μ S) of upper state, and propagation distance is about 200nm.When photosensitive particulate and When the distance of luminous particle is close enough, the singlet oxygen ion of photosensitive particulate release can reach luminous particle, and pass through a system The chemical reaction of column, launches the light of 520~620nm high level, and is detected by instrument.In this reaction system, particle Concentration is very low, and collision probability is smaller, and background signal is faint.Only photosensitive particulate and luminous particle by immune response combine with Afterwards, apparent light can just be launched, therefore the sensitivity of system is very high.In medical diagnosis on disease, common detection pattern includes three To four components: the luminous particle of envelope antigen or antibody, the antigen of biotin or digoxigenin labeled or antibody, Avidin resist The coated photosensitive particulate of digoxin neutralizes antigen or antibody etc..The above each component is resisted by the above incubation reaction of two steps with to be measured Former or antibody combines, and is qualitatively or quantitatively detected by the power of chemiluminescence amount to sample to be tested.With it is traditional enzyme-linked Immunoassay method is compared, it has the characteristics that homogeneous, high sensitivity and easy to operate is easy to automate.Therefore, before applying Scape is very wide.
It, can be because being unable to shape when material concentration height to be detected is to a certain concentration in the detection pattern of double antibodies sandwich At dual anti-sandwich complex to the relatively low phenomenon of signal value, referred to as high dose-hook effect (HD-HOOK effect).Namely It says, high dose-hook effect refers in two-site sandwich immunization experiment, the high dose section of dose-effect curve, linearly Trend instead of in platform-like it is unlimited after prolong, be turned under curved, like a hook, lead to the phenomenon that generating false negative.
In immune detection frequent occurrence, incidence accounts for positive sample 30% or so to HD-HOOK effect.Due to HD- It is since its concentration is beyond the linear of detection kit that the presence of HOOK effect, which causes to be detected sample and cannot correctly be divided into, Range or concentration itself are exactly the value, so that misdiagnosis of the experiment, especially causes false negative rate to rise.
Specifically, on the one hand, when detecting the sample of high concentration, high dose-hook effect may cause detection signal Relatively low, therefore sample is also read as relatively low concentration.The solution of the past is to increase the component of reagent, is carried out to sample to be tested Dilution or progress two-step method detection etc..
On the other hand, because of high dose-hook effect, when concentration of specimens is when being increased to certain value, signal can not be held Height of continuing rising, limits detection range.Detection range is mainly previously widened by optimization antibody or raising antibody.
Conventional detection process has following 5 steps: determinand being added in reacting hole and reagent, the first step incubate, addition is led to It is incubated and is read with liquid, second step.
Detection method of the invention is to be based on conventional detection process, more in reaction process under the premise of not interrupting reaction Secondary reading signal value, by the variation of observation signal come the actual concentration of judgement sample.
Summary of the invention
For the defect in the presence of the prior art, the purpose of the present invention is to provide a kind of method of immunity, the party Method widens detection range by reading twice, in the detection process, to pass through the amplification A that will be read twice and a known system The maximum value of the standard curve for the amplification A of column standard substance read twice compares, to judge whether sample to be tested needs to dilute It is measured again afterwards.
To achieve the goals above and other related purposes, the present invention adopts the following technical scheme:
The first aspect of the present invention provides a kind of method of immunity, which is characterized in that described method includes following steps: (1) chemiluminescence immunoassay reaction, excitation and record chemiluminescence are carried out to the sample to be tested of antigen containing object to be measured (or antibody) First time and second read, and the difference amplification between second and first time reading is denoted as A, (2) are according to containing to be measured The amplification A of the known series of standards substance of target antigen (or antibody) read twice does standard curve, wherein reference substance The concentration of matter is lower than the concentration for generating HOOK effect；(3) if the sample to be tested of antigen containing object to be measured (or antibody) twice The amplification A of reading is greater than the maximum value of the standard curve, then its concentration is more than upper limit of detection, and survey need to be diluted to sample It is fixed.
According to a preferred embodiment of the present invention, described method includes following steps:
(1) by the sample to be tested for containing object to be measured antigen (or antibody) and first antibody (or antigen) it is coated shine it is micro- Secondary antibody (or antigen) mixing of grain, label substance markers, incubates to obtain mixed liquor；
(2) it reads for the first time: adding the photosensitive micro- of marker specific bond substance markers in the mixed liquor of step (1) , exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(3) it reads for second: after the reaction solution after progress first time reading in step (2) is further incubated for, then into Row exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) x100%；
(5) according to the amplification A of the known series of standards substance of antigen containing object to be measured (or antibody) read twice Standard curve is done, wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；
(6) if the amplification A of the sample to be tested of antigen containing object to be measured (or antibody) read twice is greater than the standard The maximum value of curve, then its concentration is more than upper limit of detection, and measurement need to be diluted to sample
According to a preferred embodiment of the present invention, the known standard substance is positive control.
According to a preferred embodiment of the present invention, luminous particle refers to filled with luminophor and lanthanide series Close the high molecular particle of object；The photosensitive particulate is filled with the high molecular particle of Photoactive compounds, under red laser excitation, It can produce singlet oxygen ion.
According to a preferred embodiment of the present invention, in step (2) and (3), with the red exciting light of 600~700nm Irradiation, detects the transmitting light quantity of reaction solution；The Detection wavelength for emitting light is 520~620nm.
According to a preferred embodiment of the present invention, the antigen refers to the substance with immunogenicity；The antibody Refer to the immunoglobulin that can identify specific exotic that body generates；The first antibody and secondary antibody, which refer to, specific to be tied Together in the antibody of the target antigen；First antigen and the second antigen, which refer to, can specifically bind to the anti-of the target antibody It is former.
The second aspect of the present invention is to provide a kind of system for identifying immunoassays, the system comprises:
It is immunoreacted device, is used to implement chemiluminescence immunoassay reaction,
Chemiluminescence immunoassay reaction excitation and counting device, are used to exciting and recording chemiluminescent first time and second Secondary reading, and the difference amplification between second and first time reading is denoted as A,
Processor is used for the reading twice of the known series of standards substance according to antigen containing object to be measured (or antibody) Several amplification A, does standard curve, and wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；If containing object to be measured The amplification A of the sample to be tested of antigen (or antibody) read twice is greater than the maximum value of the standard curve, then its concentration is more than Upper limit of detection need to be diluted measurement to sample
According to a preferred embodiment of the present invention, the application method of the system includes the following steps:
(1) by the sample to be tested for containing object to be measured antigen (or antibody) and first antibody (or antigen) it is coated shine it is micro- Secondary antibody (or antigen) mixing of grain, label substance markers, incubates to obtain mixed liquor；
(2) it reads for the first time: adding the photosensitive micro- of marker specific bond substance markers in the mixed liquor of step (1) , exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(3) it reads for second: after the reaction solution after progress first time reading in step (2) is further incubated for, then into Row exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) x100%；
(5) according to the amplification A of the known series of standards substance of antigen containing object to be measured (or antibody) read twice Standard curve is done, wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；
(6) if the amplification A of the sample to be tested of antigen containing object to be measured (or antibody) read twice is greater than the standard The maximum value of curve, then its concentration is more than upper limit of detection, and measurement need to be diluted to sample
The third aspect of the present invention is to provide a kind of kit, including the coated luminous particle of first antibody (or antigen), Mark the secondary antibody (or antigen) of substance markers, the photosensitive particulate of marker specific bond substance markers, which is characterized in that the examination The application method of agent box includes the following steps: that (1) carries out chemiluminescence to the sample to be tested of antigen containing object to be measured (or antibody) It is immunoreacted, excites and record chemiluminescent first time and second reads, and will be between second and first time reading Difference amplification is denoted as A, and (2) are read twice according to the known series of standards substance of antigen containing object to be measured (or antibody) Amplification A does standard curve, and wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；(3) if it is anti-containing object to be measured The amplification A of the sample to be tested of former (or antibody) read twice is greater than the maximum value of the standard curve, then its concentration is more than inspection The upper limit is surveyed, measurement need to be diluted to sample
According to a preferred embodiment of the present invention, the application method of the kit includes the following steps:
(1) by the sample to be tested for containing object to be measured antigen (or antibody) and first antibody (or antigen) it is coated shine it is micro- Secondary antibody (or antigen) mixing of grain, label substance markers, incubates to obtain mixed liquor；
(2) it reads for the first time: adding the photosensitive micro- of marker specific bond substance markers in the mixed liquor of step (1) , exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(3) it reads for second: after the reaction solution after progress first time reading in step (2) is further incubated for, then into Row exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) x100%；
(5) according to the amplification A of the known series of standards substance of antigen containing object to be measured (or antibody) read twice Standard curve is done, wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；
(6) if the amplification A of the sample to be tested of antigen containing object to be measured (or antibody) read twice is greater than the standard The maximum value of curve, then its concentration is more than upper limit of detection, and measurement need to be diluted to sample
The object of the invention is also to provide a kind of method of immunity, widen detection range by reading twice, In the detection process, the amplification A read twice to be made comparisons with critical value, to judge after whether sample to be tested needs to dilute again It is measured.
To achieve the goals above and other related purposes, the present invention adopts the following technical scheme:
The fourth aspect of the present invention provides a kind of method of immunity, which is characterized in that described method includes following steps: (1) chemiluminescence immunoassay reaction, excitation and record chemiluminescence are carried out to the sample to be tested of antigen containing object to be measured (or antibody) First time and second read, and the difference amplification between second and first time reading is denoted as A, (2) are according to containing to be measured The amplification of the reading twice A of one known standard substance of target antigen (or antibody) does critical value, and (3) will contain object to be measured antigen The amplification A of the sample to be tested of (or antibody) read twice makes comparisons with critical value, if antigen containing object to be measured (or antibody) The amplification A read twice of sample to be tested be greater than the critical value, then judge that the concentration of sample to be tested is higher than the known mark Quasi- material concentration；If the first time reading of the sample to be tested needs to carry out sample lower than the known standard substance simultaneously It is measured again after dilution.
According to a preferred embodiment of the present invention, described method includes following steps:
(1) by the sample to be tested for containing object to be measured antigen (or antibody) and first antibody (or antigen) it is coated shine it is micro- Secondary antibody (or antigen) mixing of grain, label substance markers, incubates to obtain mixed liquor；
(2) it reads for the first time: adding the photosensitive micro- of marker specific bond substance markers in the mixed liquor of step (1) , exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(3) it reads for second: after the reaction solution after progress first time reading in step (2) is further incubated for, then into Row exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) x100%；
(5) it is done according to the amplification of the reading twice A of a known standard substance of antigen containing object to be measured (or antibody) critical Value；
(6) the amplification A of the sample to be tested for containing object to be measured antigen (or antibody) read twice is made comparisons with critical value, If the amplification A of the sample to be tested of antigen containing object to be measured (or antibody) read twice be greater than the critical value, judge to The concentration of test sample sheet is higher than the known standard substance concentration；If the first time reading gained signal value of the sample to be tested simultaneously Lower than the known standard substance, then need to be measured again after being diluted sample.
According to a preferred embodiment of the present invention, the known standard substance is positive control.
According to a preferred embodiment of the present invention, luminous particle refers to filled with luminophor and lanthanide series Close the high molecular particle of object；The photosensitive particulate is filled with the high molecular particle of Photoactive compounds, under red laser excitation, It can produce singlet oxygen ion.
According to a preferred embodiment of the present invention, in step (2) and (3), with the red exciting light of 600~700nm Irradiation, detects the transmitting light quantity of reaction solution；The Detection wavelength for emitting light is 520~620nm.
According to a preferred embodiment of the present invention, the antigen refers to the substance with immunogenicity；The antibody Refer to the immunoglobulin that can identify specific exotic that body generates；The first antibody and secondary antibody, which refer to, specific to be tied Together in the antibody of the target antigen；First antigen and the second antigen, which refer to, can specifically bind to the anti-of the target antibody It is former.
The fifth aspect of the present invention provides a kind of system for identifying immunoassays, the system comprises:
It is immunoreacted device, is used to implement chemiluminescence immunoassay reaction,
Chemiluminescence immunoassay reaction excitation and counting device, are used to exciting and recording chemiluminescent first time and second Secondary reading, and the difference amplification between second and first time reading is denoted as A,
Processor is used to contain the amplification A read twice of the sample to be tested of object to be measured antigen (or antibody) and face Dividing value is made comparisons, if the amplification A of the sample to be tested of antigen containing object to be measured (or antibody) read twice is greater than described critical Value then judges that the concentration of sample to be tested is higher than the concentration of the known standard substance, if the first time of the sample to be tested simultaneously Reading then needs to be measured again after being diluted sample lower than the known standard substance.
In a specific embodiment, the system that the present invention is used to identify immunoassays includes immune response device, Such as hold the container of solution；Chemiluminescence immunoassay reaction excitation and counting device, such as photon counting module and light-emitting diodes Pipe；And processor, such as computer, the reading is handled and mapped.This system for identifying immunoassays The application can be incorporated by reference for example with reference to the utility model patent CN201532646U of the applicant.
According to a preferred embodiment, the application method of the system includes the following steps:
(1) by the sample to be tested for containing object to be measured antigen (or antibody) and first antibody (or antigen) it is coated shine it is micro- Secondary antibody (or antigen) mixing of grain, label substance markers, incubates to obtain mixed liquor；
(2) it reads for the first time: adding the photosensitive micro- of marker specific bond substance markers in the mixed liquor of step (1) , exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(3) it reads for second: after the reaction solution after progress first time reading in step (2) is further incubated for, then into Row exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) x100%；
(5) it is done according to the amplification of the reading twice A of a known standard substance of antigen containing object to be measured (or antibody) critical Value；
(6) the amplification A of the sample to be tested for containing object to be measured antigen (or antibody) read twice is made comparisons with critical value, If the amplification A of the sample to be tested of antigen containing object to be measured (or antibody) read twice be greater than the critical value, judge to The concentration of test sample sheet is higher than the concentration of the known standard substance；If the first time reading gained signal of the sample to be tested simultaneously Value then needs to be measured again after being diluted sample lower than the known standard substance.
The sixth aspect of the present invention provides a kind of kit, including the coated luminous particle of first antibody (or antigen), mark Remember the secondary antibody (or antigen) of substance markers, the photosensitive particulate of marker specific bond substance markers, which is characterized in that the reagent The application method of box includes the following steps: that (1) carries out chemiluminescence to the sample to be tested of antigen containing object to be measured (or antibody) and exempts from Epidemic disease reaction, exciting and record chemiluminescent first time and second reads, and by the difference between second and first time reading Value amplification is denoted as A, and (2) are done according to the amplification of the reading twice A of a known standard substance of antigen containing object to be measured (or antibody) Critical value, (3) make comparisons the amplification A of the sample to be tested for containing object to be measured antigen (or antibody) read twice with critical value, If the amplification A of the sample to be tested of antigen containing object to be measured (or antibody) read twice be greater than the critical value, judge to The concentration of test sample sheet is higher than the concentration of the known standard substance；If the first time reading of the sample to be tested is lower than described simultaneously Known standard substance then needs to be measured again after being diluted sample.
According to a preferred embodiment of the present invention, the application method of the kit includes the following steps:
(1) by the sample to be tested for containing object to be measured antigen (or antibody) and first antibody (or antigen) it is coated shine it is micro- Secondary antibody (or antigen) mixing of grain, label substance markers, incubates to obtain mixed liquor；
(2) it reads for the first time: adding the photosensitive micro- of marker specific bond substance markers in the mixed liquor of step (1) , exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(3) it reads for second: after the reaction solution after progress first time reading in step (2) is further incubated for, then into Row exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) x100%；
(5) it is done according to the amplification of the reading twice A of a known standard substance of antigen containing object to be measured (or antibody) critical Value；
(6) the amplification A of the sample to be tested for containing object to be measured antigen (or antibody) read twice is made comparisons with critical value, If the amplification A of the sample to be tested of antigen containing object to be measured (or antibody) read twice be greater than the critical value, judge to The concentration of test sample sheet is higher than the concentration of the known standard substance；If the first time reading gained signal of the sample to be tested simultaneously Value then needs to be measured again after being diluted sample lower than the known standard substance.
Here, the method is used for double it should be strongly noted that the above method is the method for non-disease diagnostic purpose In antibody sandwich immunization or double antigens sandwich immunization detection process, widen detection range by reading twice, with In detection process, the amplification A read twice is made comparisons with critical value, to judge whether sample to be tested needs to carry out again after diluting Measurement.
Preferably, the antigen refers to the substance with immunogenicity.Such as protein, polypeptide.Representative antigen packet It includes (but being not limited to): cell factor, tumor markers, Matrix metalloprotease-9, cardiovascular diabetes related protein etc..
The antibody refers to the immunoglobulin that can identify specific exotic that body generates.
In the embodiment of the present invention, the antigen or antibody are selected from HBsAb anti-HBs (HBsAb), people Chorionic gonadotrophin swash and β subunit (HCG+ β), hepatitis B surface antigen (HBsAg), cancer antigen 125 (CA125), C peptide (CP), Ferritin (Ferr) and Anti-HCV.
It can be not particularly limited, be can be any (or anti-containing object to be measured antigen with the sample that the method for the present invention detects Body) sample, representative example may include serum sample, urine specimen, saliva sample etc..Currently preferred sample is blood Final proof sheet.
Preferably, the first antibody and secondary antibody refer to the antibody that can specifically bind to the antigen.
For same antigen, corresponding first antibody and secondary antibody can be it is identical be also possible to it is different, And it can be in combination in the antigen.
First antigen and the second antigen refer to the antigen that can specifically bind to the target antibody.
For same antibody, corresponding first antigen and the second antigen can be it is identical be also possible to it is different, And it can be in combination in the antibody.
Preferably, it can be specifically bound between the marker and marker specific junction mixture.
It is furthermore preferred that the marker is biotin, the marker specific junction mixture is Streptavidin.
Preferably, the luminous particle refers to the high molecular particle filled with luminophor and lanthanide compound. Luminophor can be the derivative etc. of Dioxene (dioxine) or thioxene (thioxene), group of the lanthanides member Plain compound can be Eu (TTA)3/ TOPO or Eu (TTA)3/ Phen etc., the particle can be by buying in the market.The table of luminous particle Face functional group can be the group of any energy connexin matter, and such as carboxyl, aldehyde radical, amido, epoxy ethyl or halogenated alkyl etc. are each The functional group of protein can be connected known to kind.
Preferably, the photosensitive particulate is filled with the high molecular particle of Photoactive compounds, can under red laser excitation To generate singlet oxygen ion.In the case that when it, distance is close enough with luminous particle, single line oxonium ion is transmitted to luminous particle, It is reacted with the luminophor in luminous particle, generates ultraviolet light, ultraviolet light further excites lanthanide compound, generates The photon of certain wavelength.Photoactive compounds can be phthalocyanine dye etc., which can also be by buying in the market.
Preferably, it in step (2) and (3), is irradiated with the red exciting light of 600~700nm, detects the transmitting of reaction solution Light quantity.The Detection wavelength for emitting light is 520~620nm.
Further, red laser (600~700nm) irradiation photosensitive particulate, the singlet oxygen ion of photosensitive particulate release, A part of singlet oxygen ion is received by luminous particle, to launch the light of 520~620nm high level.
In detection range, the concentration of object to be measured antigen shows as the quantity of double-antibody sandwich compound, and and photon Number is directly proportional；But when object to be measured antigen concentration is excessively high, part determined antigen in conjunction with single antibody, leads to dual anti-folder respectively Heart compound is reduced, and optical signal is relatively low, cannot reflect the actual concentration of object to be measured antigen.
Similarly, in detection range, the concentration of object to be measured antibody shows as the quantity of double antigens sandwich compound, and with Number of photons is directly proportional；But when object to be measured antibody concentration is excessively high, part test antibodies with single antigen binding, cause double respectively Antigen sandwich compound is reduced, and optical signal is relatively low, cannot reflect the actual concentration of object to be measured antibody.
Method of the invention reads the relationship between gained signal value amplification by reading twice more twice, so as to To play the role of widening detection range and distinguish HD-HOOK effect sample.The difference read twice is determined by following three aspects It is fixed:
In a first aspect, after photosensitive particulate is irradiated by red laser (600~700nm), releasing single line when reading for the first time State oxonium ion.After a part of singlet oxygen ion transport to luminous particle, by a series of chemical reaction, launch 520~ The light of 620nm high level；And a part of singlet oxygen ion then with not by antibody (or antigen) combine object to be measured antigen (or Antibody) reaction, so that the concentration of object to be measured antigen (or antibody) reduces.For the sample of low concentration, object to be measured antigen (or Antibody) after concentration decline, double antibodies sandwich compound is reduced, and second of read signal value can reduce；And for high concentration sample, to After surveying the reduction of target antigen (or antibody) concentration, double antibodies sandwich compound increases, and second of read signal value increases instead.
Second aspect, for low concentration sample, photosensitive particulate is in first time reading process by red laser (600 ~700nm) irradiation, after discharging singlet oxygen ion, energy is lost, and second of read signal can reduce.
The third aspect, for HD-HOOK effect, when reading for the first time, balance is had not yet been reached in antigen-antibody reaction, The interval time read twice, reaction can still be carried out towards positive direction, and second of read signal can increase.
In conclusion the present invention carries out first time reading, the irradiation of photosensitive particulate stimulated luminescence when reaction not up to balances Discharge singlet oxygen, a part is transmitted to luminous particle, a part can with unbonded target antigen or antibody response to be detected, Part target antigen to be detected or antibody are consumed, so that reaction balance is reverse mobile, another aspect photosensitive particulate was exciting one It after secondary, is lost, when second reads, the signal value of object to be measured antigen or the low sample of antibody concentration can be reduced；And The combination of the double antibodies sandwich compound and photosensitive particulate of the high sample of concentration reaches far away balance when reading first time, second of reading Reaction can be mobile towards positive reaction direction when number, so signal can increase, with the raising of object to be measured antigen (or antibody) concentration, The signal value of second of phot-luminescence and the amplitude that increases of first time signal value also increase.The amplification and concentration of specimens positive of signal It closes, the amplification A of signal twice is made comparisons with critical value, to judge whether sample to be tested needs to be measured again after diluting.
Compared with prior art, the invention has the benefit that
(1) it the present invention is based on the homogeneity of the disposable of light-induced chemiluminescent platform (luminescent oxygen channel) and reaction, is able to achieve Progress of the multiple signal measurement without interrupting immune response is carried out to a reaction, detects to believe in the light of differential responses time Number, the not examined scope limitation of the method effectively widens 100 times of detection range or more.
(2) whether the sample to be tested that method of the invention can identify in double-antibody method detection needs to carry out again after diluting Measurement, the method can significantly improve the accuracy of double antibody sandwich method immunoassays, and it is immune to reduce double antibody sandwich method The false negative rate of measurement.
(3) method of the invention is easy to operate, can identify non-disease diagnostic purpose double-antibody sandwich simple and effectively and exempt from The relatively low sample of reported concentrations caused by HD-HOOK effect in epidemic disease measurement.
Detailed description of the invention
Fig. 1: HCG+ β is using signal value obtained by conventional method and concentration of specimens graph of relation；
Fig. 2: HCG+ β using signal value obtained by the method for the present invention and A respectively with concentration of specimens graph of relation.
Specific embodiment
Before further describing the specific embodiments of the present invention, it should be appreciated that protection scope of the present invention is not limited to down State specific specific embodiment；It is also understood that term used in the embodiment of the present invention is specific specific in order to describe Embodiment, rather than limiting the scope of protection of the present invention.
When embodiment provides numberical range, it should be appreciated that except non-present invention is otherwise noted, two ends of each numberical range Any one numerical value can be selected between point and two endpoints.Unless otherwise defined, the present invention used in all technologies and Scientific term is identical as the normally understood meaning of those skilled in the art of the present technique.Except specific method, equipment used in embodiment, Outside material, grasp and record of the invention according to those skilled in the art to the prior art can also be used and this Any method, equipment and the material of the similar or equivalent prior art of method described in inventive embodiments, equipment, material come real The existing present invention.
Unless otherwise stated, disclosed in this invention experimental method, detection method, preparation method be all made of this technology neck Molecular biology, biochemistry, chromatin Structure and the analysis of domain routine, analytical chemistry, cell culture, recombinant DNA technology and The routine techniques of related fields.These technologies have perfect explanation in the prior art, and for details, reference can be made to Sambrook etc. MOLECULAR CLONING:A LABORATORY MANUAL, Second edition, Cold Spring Harbor Laboratory Press, 1989and Third edition, 2001；Ausubel etc., CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley&Sons, New York, 1987and periodic updates；the Series METHODS IN ENZYMOLOGY, Academic Press, San Diego；Wolffe, CHROMATIN STRUCTURE AND FUNCTION, Third edition, Academic Press, San Diego, 1998；METHODS IN ENZYMOLOGY, Vol.304, Chromatin (P.M.Wassarman and A.P.Wolffe, eds.), Academic Press, San Diego, 1999；With METHODS IN MOLECULAR BIOLOGY, Vol.119, Chromatin Protocols (P.B.Becker, ed.) Humana Press, Totowa, 1999 etc..
The present inventor has found after extensive and in-depth study, is read twice by setting up, and will read twice Amplification A make comparisons with critical value, can determine whether sample to be tested whether need dilute after be measured again.
As described herein, term " first antibody " and " secondary antibody ", which refer to, can specifically bind to a certain antigen (as swollen Tumor markers) antibody.For same antigen (such as tumor markers), corresponding first antibody and secondary antibody be can be Different being also possible to is identical, and can be in combination in the antigen.Term " the first antigen " and " the second antigen " refer to It can specifically bind to the antigen of a certain antibody (such as hepatitis B surface antibody).For same antibody (such as hepatitis B surface antibody) Speech, corresponding first antigen and the second antigen can be different be also possible to it is identical, and can be in combination in described Antibody.
As described herein, term " antigen " refers to the substance with immunogenicity, such as protein, polypeptide.It is representative Antigen include but is not limited to: cell factor, tumor markers, Matrix metalloprotease-9, cardiovascular diabetes related protein etc..
As described herein, term " tumor markers " refers in the generation and breeding of tumour, by tumour cell Either tumour cell reaction is generated by body caused by itself, reaction tumour exists and a substance of growth. The representative tumor markers in this field include but is not limited to: alpha-fetoprotein (AFP), cancer antigen 125 (CA125) etc..
The basic principle of double-antibody method:
The basic principle of double antibody sandwich method is well-known to those skilled in the art.Conventional way is by first antibody It is fixed on solid phase carrier, then by first antibody and antigen-reactive, then is reacted with the secondary antibody of label, chemical hair is finally carried out Light or enzyme-linked chromogenic reaction detect signal.
The basic principle of light-induced chemiluminescent method:
The basic principle of light-induced chemiluminescent method is well-known to those skilled in the art.Conventional way is by photosensitive Particle and luminous particle combine in a certain range, generate the transmitting of ion oxygen energy, optical signal are issued, thus to sample to be tested It is detected.Wherein, it is filled with Photoactive compounds inside photosensitive particulate, and is filled with luminophor and lanthanum inside luminous particle Series elements.Under the excitation of red laser (600~700nm), photosensitive particulate releases singlet oxygen ion (4 μ of upper state S), propagation distance is about 200nm.When the distance of photosensitive particulate and luminous particle is close enough, the list of photosensitive particulate release Line state oxonium ion can reach luminous particle, and by a series of chemical reaction, launch the light of 520~620nm high level, and It is detected by instrument.
In a preferred embodiment of the invention, the feature that first antibody is fixed in luminous particle is taken full advantage of, Biotin labeling secondary antibody is used simultaneously, and Streptavidin is coated with photosensitive particulate, by serum sample or antigen standard quality-control product Liquid and the coated luminous particle of first antibody, biotin labeling secondary antibody are sequentially or simultaneously added in reaction vessel, add The photosensitive particulate of marked by streptavidin, so that following reaction occur:
(1) first antibody in luminous particle and corresponding antigen binding in serum sample or antigen standard quality-control product liquid, Form " antigen-first antibody-luminous particle " ternary complex；
(2) secondary antibody and corresponding antigen binding in serum sample or antigen standard quality-control product liquid, ultimately form " second Antibody-antigene-first antibody-luminous particle " double antibodies sandwich compound；
Biotin and Streptavidin specific binding, so that double antibodies sandwich compound is combined with photosensitive particulate.
At this point, the distance between photosensitive particulate and luminous particle are less than 200nm, red laser (600~700nm) irradiation sense After light particles, the singlet oxygen of release can be received by luminous particle.By series of chemical, launch 520~620nm The light of high level, and sample to be tested is qualitatively or quantitatively detected by the power of chemiluminescence amount.
In another preferred embodiment of the invention, the spy that the first antigen is fixed in luminous particle is taken full advantage of Point, while the second antigen of biotin labeling is used, Streptavidin is coated with photosensitive particulate, by serum sample or antigen standard Quality Control The luminous particle of product liquid and the first antigen coat, the second antigen of biotin labeling are sequentially or simultaneously added in reaction vessel, then plus Enter the photosensitive particulate of marked by streptavidin, so that following reaction occur:
(1) the first antigen in luminous particle is tied with antibody corresponding in serum sample or antigen standard quality-control product liquid product It closes, forms " the-the first antigen of antibody-luminous particle " ternary complex；
(2) second antigens ultimately form " second in conjunction with corresponding antibody in serum sample or antigen standard quality-control product liquid The-the first antigen of Ag-Ab-luminous particle " double antibodies sandwich compound；
Biotin and Streptavidin specific binding, so that double antibodies sandwich compound is combined with photosensitive particulate.
At this point, the distance between photosensitive particulate and luminous particle are less than 200nm, red laser (600~700nm) irradiation sense After light particles, the singlet oxygen of release can be received by luminous particle.By series of chemical, launch 520~620nm The light of high level, and sample to be tested is qualitatively or quantitatively detected by the power of chemiluminescence amount.
Hereinafter, further illustrating relevant operation details of the invention.
(1) first antibody (or antigen) coated luminous particle, is denoted as reagent 1, and it is limited to can purchase Yu Boyang biotechnology Company.
(2) secondary antibody (or antigen) can be marked with various markers known in the art and its specific junction mixture system Note.Secondary antibody (or antigen) is marked preferably by biotin-avidin system.Biotin labeling secondary antibody (or Antigen), it is denoted as reagent 2, can purchase Yu Boyang Biotechnology Co., Ltd.
(3) the coated photosensitive particulate of Streptavidin is denoted as general liquid, can purchase Yu Boyang Biotechnology Co., Ltd.
(4) standard items:
It is molten with the standard items for (being lower than HD-HOOK effective concentration) within the scope of determined antigen (or antibody) configuration a certain concentration Liquid.Standard items, reagent 1, reagent 2 are mixed, general liquid is added after incubation reaction, after continuing incubation reaction for a period of time for the first time It reads (RLU1), then carries out second of reading (RLU2) after incubating a period of time, calculate A=(RLU2/RLU1-1) x100%, root According to standard items RLU1 and twice the amplification A that reads does standard curve with standard concentration respectively；
(5) detection of sample:
It can be not particularly limited with the sample that the method for the present invention detects, can be any sample containing antigen (or antibody) Product, representative example may include serum sample, urine specimen, saliva sample etc..Preferred sample is blood serum sample.
(6) sample concentration calculates:
Sample to be tested is read to amplification A value twice compared with the A of known standard items, if sample to be tested A is greater than known standard The A of product, then this concentration of specimens is greater than the concentration of known standard items；If this sample RLU1 is less than the RLU1 of this standard items simultaneously, Show the RLU1 of this sample it is low be to need to dilute detection as caused by HD-HOOK effect.
Embodiment 1: human chorionic gonadotrophin and β subunit (HCG+ β) the verifying present invention in detection human serum sample Method validity
The human chorionic gonadotrophin and β subunit (HCG+ produced using Bo Yang biotechnology (Shanghai) Co., Ltd. β) detection kit (light-induced chemiluminescent method) detects human chorionic gonadotrophin and β subunit (HCG+ in serum sample Content β).The kit include calibration object 1- calibration object 6, reagent 1 (illuminating antibody, also that is, antibody it is coated shine it is micro- Grain), reagent 2 (biotin labelled antibodies, that is, the antibody of biotin labeling).
To detected by Roche (more than detection limit sample be diluted detect) 18 HCG+ β concentration patients serum's sample This, carries out conventional method and the method for the present invention detection respectively,
Common detection methods: by sample to be tested, the calibration object, (illuminating antibody, also that is, mouse monoclonal antibody is coated of reagent 1 Luminous particle) and reagent 2 (biotin labelled antibodies, that is, the mouse monoclonal antibody of biotin labeling) be separately added into reaction cup Afterwards, 37 DEG C of incubation 15min are added general liquid (photosensitive particulate of marked by streptavidin), 37 DEG C of incubation 10min, photon counting Device reading, reads RLU, calculates to obtain concentration of specimens, as a result as shown in the table.
Using method of reading twice of the invention: by sample to be tested, the calibration object, (illuminating antibody, also that is, murine monoclonal is anti-of reagent 1 The coated luminous particle of body) and reagent 2 (biotin labelled antibodies, that is, the mouse monoclonal antibody of biotin labeling), 37 DEG C of temperature 15min is educated, is added general liquid (photosensitive particulate of marked by streptavidin), 37 DEG C of incubation 3min read RLU1,37 DEG C of continuation temperature 7min is educated, RLU2 is read, and calculate amplification A=(RLU2/RLU1-1) X100% of second of signal value, as a result such as following table institute Show,
Table 1:
Note: the detection range of HCG+ β conventional detection is 0-10000mIU/ml, be beyond upper limit of detection sample display density > 10000mIU/ml。
Roche testing result is as actual concentration, and by table 1 and Fig. 1 it is found that in conventional detection, concentration is risen to 54531mIU/ml signal value increases with concentration and is increased, and concentration continues to increase, and signal value is increased with HCG+ β concentration and reduced, i.e., Concentration is greater than 54531mIU/ml then HD-HOOK, in conventional detection, detection range 0-10000mIU/ml, beyond in detection Limiting sample display density is > 10000mIU/ml, and when HD-HOOK effect concentration of specimens persistently increases, signal is continued to decline, will Occur ultrahigh concentration sample report at relatively low concentration levels, such as sample 18.So cannot be differentiated in conventional detection to be measured The testing result of sample is actual concentration or the relatively low concentration that superelevation value sample is reported by HD-HOOK effects.
The method of the present invention identifies the relatively low sample of reported concentrations caused by HOOK effect by reading twice.Each to test sample This successively detects signal value result RLU1, RLU2, using amplification A=(RLU2/RLU1-1) X100% of second of reading as One of the index of judgement sample concentration.By table 1 and Fig. 2 it is found that signal value is increased to 54531mIU/ml, Zhi Houxin with concentration is continuous Number value starts to increase and decline with concentration, but amplification A is persistently to rise with concentration.Therefore the directly relatively A of sample to be tested The A value of value and calibration object, that is, can determine whether the size relation of sample to be tested concentration Yu calibration object concentration.The amplification A of sample 10~18 It is all larger than the amplification (11.1%) of calibration object 6, and A value persistently increases, shows that the HCG+ β concentration of sample 10~18 is all larger than 10000mIU/ml, and concentration persistently increases, this is consistent with the concentration results of Roche, and 18 signal value of sample is lower than calibration object 6, often Rule method detectable concentration is 8713.02mIU/ml, can identify it by the method for the invention as HD-HOOK effect sample, need to carry out Dilution detection.
The above-described embodiments merely illustrate the principles and effects of the present invention, and is not intended to limit the present invention.It is any ripe The personage for knowing this technology all without departing from the spirit and scope of the present invention, carries out modifications and changes to above-described embodiment.Cause This, institute is complete without departing from the spirit and technical ideas disclosed in the present invention by those of ordinary skill in the art such as At all equivalent modifications or change, should be covered by the claims of the present invention.

Claims (42)

1. a kind of human chorionic gonadotropin's gland swashs and the method for immunity of β subunit, which is characterized in that the method includes as follows Step: (1) swashing gland containing human chorionic gonadotropin and the sample to be tested of β subunit carries out chemiluminescence immunoassay reaction, excitation and note It records chemiluminescent first time and second reads, and the difference amplification between second and first time reading is denoted as A, (2) Swashed according to gland containing human chorionic gonadotropin and the amplification A ' of the known series of standards substance of β subunit read twice does standard Curve, wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；(3) if gland containing human chorionic gonadotropin swashs and β is sub- The amplification A of the sample to be tested of unit read twice is greater than the maximum value of the standard curve, then after being diluted to sample again It is measured.
2. method of immunity according to claim 1, which is characterized in that described method includes following steps:
(a1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, label The secondary antibody of substance markers mixes, and incubates to obtain mixed liquor；
(a2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (a1), Exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(a3) it reads for second: after the reaction solution after progress first time reading in step (a2) is further incubated for, then carrying out Exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(a4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(a5) according to gland containing human chorionic gonadotropin swash and β subunit known series of standards substance the amplification read twice A ' does standard curve, and wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；
(a6) if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the mark The maximum value of directrix curve, then be measured after being diluted to sample again.
3. method of immunity according to claim 1, which is characterized in that the known standard substance is positive control.
4. method of immunity according to claim 2, which is characterized in that luminous particle refers to filled with luminophor With the high molecular particle of lanthanide compound；The photosensitive particulate is filled with the high molecular particle of Photoactive compounds, red Under color laser excitation, singlet oxygen ion can produce.
5. method of immunity according to claim 2, which is characterized in that in step (a2) and (a3), with 600~ The red exciting light of 700nm irradiates, and detects the transmitting light quantity of reaction solution；The Detection wavelength for emitting light is 520~620nm.
6. method of immunity according to claim 2, which is characterized in that the antibody refers to capable of identifying for body generation The immunoglobulin of specific exotic；The first antibody and secondary antibody, which refer to, can specifically bind to the human chorionic gonadotropin Gland swashs and the antibody of β subunit.
7. it is a kind of for surveyor's chorionic gonadotrophin swash and the immunoassays of β subunit system, the system comprises:
It is immunoreacted device, is used to implement chemiluminescence immunoassay reaction,
Chemiluminescence immunoassay reaction excitation and counting device, are used to excite and record chemiluminescent first time and second is read Number, and the difference amplification between second and first time reading is denoted as A,
Processor, be used for according to gland containing human chorionic gonadotropin swash and β subunit known series of standards substance twice The amplification A ' of reading does standard curve, and wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；If containing human chorionic Film promote sexual gland swash and β subunit sample to be tested the amplification A read twice be greater than the standard curve maximum value, then to sample Product are measured again after being diluted.
8. system according to claim 7, which is characterized in that the application method of the system includes the following steps:
(1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, marker The secondary antibody of label mixes, and incubates to obtain mixed liquor；
(2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (1), temperature Exciting light irradiation is carried out after educating and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(3) it reads for second: after the reaction solution after progress first time reading in step (2) is further incubated for, then being swashed It shines and irradiates and detect transmitting light quantity, photon counter reading is calculated as RLU2；
(4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(5) according to gland containing human chorionic gonadotropin swash and β subunit known series of standards substance the amplification read twice A ' does standard curve, and wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；
(6) if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the standard The maximum value of curve, then be measured after being diluted to sample again.
9. system according to claim 7, which is characterized in that the known standard substance is positive control.
10. system according to claim 8, which is characterized in that luminous particle refers to filled with luminophor and group of the lanthanides The high molecular particle of element compound；The photosensitive particulate is filled with the high molecular particle of Photoactive compounds, in red laser Under excitation, singlet oxygen ion can produce.
11. system according to claim 7, which is characterized in that in step (2) and (3), swashed with the red of 600~700nm Shine irradiation, detects the transmitting light quantity of reaction solution；The Detection wavelength for emitting light is 520~620nm.
12. system according to claim 7, which is characterized in that the antibody refers to that capable of identifying for body generation is specific outer Carry out the immunoglobulin of object；The first antibody and secondary antibody refer to can specifically bind to human chorionic gonadotropin's gland swash and The antibody of β subunit.
13. a kind of detection human chorionic gonadotropin's gland swashs and the kit of β subunit, including the coated luminous particle of first antibody, Mark the secondary antibody of substance markers, the photosensitive particulate of marker specific bond substance markers, which is characterized in that the kit makes Include the following steps: that (1) swashs gland containing human chorionic gonadotropin and the sample to be tested of β subunit carries out chemiluminescence immunoassay with method Reaction, exciting and record chemiluminescent first time and second reads, and by the difference between second and first time reading Amplification is denoted as A, and (2) are swashed according to gland containing human chorionic gonadotropin and the reading twice of the known series of standards substance of β subunit Amplification A ' do standard curve, wherein the concentration of standard substance lower than generate HOOK effect concentration；(3) if containing human chorionic Promote sexual gland swash and β subunit sample to be tested the amplification A read twice be greater than the standard curve maximum value, then to sample It is measured again after being diluted.
14. kit according to claim 13, which is characterized in that the application method of the kit includes following step It is rapid:
(a1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, label The secondary antibody of substance markers mixes, and incubates to obtain mixed liquor；
(a2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (a1), Exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(a3) it reads for second: after the reaction solution after progress first time reading in step (a2) is further incubated for, then carrying out Exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(a4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(a5) according to gland containing human chorionic gonadotropin swash and β subunit known series of standards substance the amplification read twice A ' does standard curve, and wherein the concentration of standard substance is lower than the concentration for generating HOOK effect；
(a6) if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the mark The maximum value of directrix curve, then be measured after being diluted to sample again.
15. kit described in 3 or 14 according to claim 1, which is characterized in that the known standard substance is positive control.
16. kit according to claim 14, which is characterized in that luminous particle refers to filled with luminophor and lanthanum The high molecular particle of series elements compound；The photosensitive particulate is filled with the high molecular particle of Photoactive compounds, swashs in red Under light excitation, singlet oxygen ion can produce.
17. kit according to claim 14, which is characterized in that in step (a2) and (a3), with 600~700nm's Red exciting light irradiation, detects the transmitting light quantity of reaction solution；The Detection wavelength for emitting light is 520~620nm.
18. kit according to claim 14, which is characterized in that the antibody refers to that capable of identifying for body generation is specific The immunoglobulin of exotic；The first antibody and secondary antibody refer to that can specifically bind to human chorionic gonadotropin's gland swashs And the antibody of β subunit.
19. a kind of human chorionic gonadotropin's gland swashs and the method for immunity of β subunit, which is characterized in that the method includes such as Lower step: (1) to gland containing human chorionic gonadotropin swash and β subunit sample to be tested carry out chemiluminescence immunoassay reaction, excitation and It records chemiluminescent first time and second reads, and the difference amplification between second and first time reading is denoted as A, (2) swashed according to gland containing human chorionic gonadotropin and the amplification of the reading twice A ' of a known standard substance of β subunit do critical value, (3) gland containing human chorionic gonadotropin is swashed and the amplification A of the sample to be tested of β subunit read twice makes comparisons with critical value, such as Fruit gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the critical value, then described The concentration of sample to be tested is higher than the concentration of known standard substance.
20. a kind of human chorionic gonadotropin's gland swashs and the method for immunity of β subunit, which is characterized in that the method includes such as Lower step: (1) to gland containing human chorionic gonadotropin swash and β subunit sample to be tested carry out chemiluminescence immunoassay reaction, excitation and It records chemiluminescent first time and second reads, and the difference amplification between second and first time reading is denoted as A, (2) swashed according to gland containing human chorionic gonadotropin and the amplification of the reading twice A ' of a known standard substance of β subunit do critical value, (3) gland containing human chorionic gonadotropin is swashed and the amplification A of the sample to be tested of β subunit read twice makes comparisons with critical value, such as Fruit gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the critical value, and simultaneously The first time reading of the sample to be tested is measured after being then diluted to sample again lower than the known standard substance.
21. method of immunity according to claim 19, which is characterized in that described method includes following steps:
(a1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, label The secondary antibody of substance markers mixes, and incubates to obtain mixed liquor；
(a2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (a1), Exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(a3) it reads for second: after the reaction solution after progress first time reading in step (a2) is further incubated for, then carrying out Exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(a4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(a5) swashed according to gland containing human chorionic gonadotropin and the amplification of the reading twice A ' of a known standard substance of β subunit does and faces Dividing value；
(a6) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested the amplification A read twice and critical value make ratio Compared with, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the critical value, Then the concentration of the sample to be tested is higher than the concentration of the known standard substance.
22. method of immunity according to claim 20, which is characterized in that described method includes following steps:
(a1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, label The secondary antibody of substance markers mixes, and incubates to obtain mixed liquor；
(a2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (a1), Exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(a3) it reads for second: after the reaction solution after progress first time reading in step (a2) is further incubated for, then carrying out Exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(a4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(a5) swashed according to gland containing human chorionic gonadotropin and the amplification of the reading twice A ' of a known standard substance of β subunit does and faces Dividing value；
(a6) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested the amplification A read twice and critical value make ratio Compared with, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the critical value, And the first time reading gained signal value of the sample to be tested is then diluted sample lower than the known standard substance simultaneously It is measured again afterwards.
23. method of immunity described in 9 or 20 according to claim 1, which is characterized in that the known standard substance is positive Control.
24. the method for immunity according to claim 21 or 22, which is characterized in that luminous particle refers to filled with luminous The high molecular particle of compound and lanthanide compound；The macromolecule that the photosensitive particulate is filled with Photoactive compounds is micro- Grain can produce singlet oxygen ion under red laser excitation.
25. the method for immunity according to claim 21 or 22, which is characterized in that in step (a2) and (a3), with 600 The red exciting light of~700nm irradiates, and detects the transmitting light quantity of reaction solution；The Detection wavelength for emitting light is 520~620nm.
26. the method for immunity according to claim 21 or 22, which is characterized in that the antibody refers to what body generated It can identify the immunoglobulin of specific exotic；The first antibody and secondary antibody, which refer to, can specifically bind to the human chorionic Film rush sexual gland swashs and the antibody of β subunit.
27. it is a kind of for surveyor's chorionic gonadotrophin swash and the immunoassays of β subunit system, the system comprises:
It is immunoreacted device, is used to implement chemiluminescence immunoassay reaction,
Chemiluminescence immunoassay reaction excitation and counting device, are used to excite and record chemiluminescent first time and second is read Number, and the difference amplification between second and first time reading is denoted as A,
Processor, be used for will contain human chorionic gonadotropin's gland swash and β subunit sample to be tested the amplification A read twice with face Dividing value is made comparisons, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than described Critical value, then the concentration of the sample to be tested is higher than the concentration of the known standard substance.
28. it is a kind of for surveyor's chorionic gonadotrophin swash and the immunoassays of β subunit system, the system comprises:
It is immunoreacted device, is used to implement chemiluminescence immunoassay reaction,
Chemiluminescence immunoassay reaction excitation and counting device, are used to excite and record chemiluminescent first time and second is read Number, and the difference amplification between second and first time reading is denoted as A,
Processor, be used for will contain human chorionic gonadotropin's gland swash and β subunit sample to be tested the amplification A read twice with face Dividing value is made comparisons, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than described Critical value, and the first time reading gained signal value of the sample to be tested is lower than the known standard substance simultaneously, then to sample It is measured again after being diluted.
29. system according to claim 27, which is characterized in that the application method of the system includes the following steps:
(a1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, label The secondary antibody of substance markers mixes, and incubates to obtain mixed liquor；
(a2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (a1), Exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(a3) it reads for second: after the reaction solution after progress first time reading in step (a2) is further incubated for, then carrying out Exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(a4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(a5) swashed according to gland containing human chorionic gonadotropin and the amplification of the reading twice A ' of a known standard substance of β subunit does and faces Dividing value；
(a6) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested the amplification A read twice and critical value make ratio Compared with, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the critical value, Then the concentration of the sample to be tested is higher than the concentration of the known standard substance.
30. system according to claim 28, which is characterized in that the application method of the system includes the following steps:
(a1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, label The secondary antibody of substance markers mixes, and incubates to obtain mixed liquor；
(a2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (a1), Exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(a3) it reads for second: after the reaction solution after progress first time reading in step (a2) is further incubated for, then carrying out Exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(a4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(a5) swashed according to gland containing human chorionic gonadotropin and the amplification of the reading twice A ' of a known standard substance of β subunit does and faces Dividing value；
(a6) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested the amplification A read twice and critical value make ratio Compared with, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the critical value, And the first time reading gained signal value of the sample to be tested is then diluted sample lower than the known standard substance simultaneously It is measured again afterwards.
31. system according to claim 27, which is characterized in that the known standard substance is positive control.
32. the system according to claim 29 or 30, which is characterized in that luminous particle refer to filled with luminophor and The high molecular particle of lanthanide compound；The photosensitive particulate is filled with the high molecular particle of Photoactive compounds, in red Under laser excitation, singlet oxygen ion can produce.
33. the system according to claim 29 or 30, which is characterized in that in step (a2) and (a3), with 600~700nm Red exciting light irradiation, detect the transmitting light quantity of reaction solution；The Detection wavelength for emitting light is 520~620nm.
34. system according to claim 27, which is characterized in that the antibody refers to that capable of identifying for body generation is specific outer Carry out the immunoglobulin of object；The first antibody and secondary antibody refer to can specifically bind to human chorionic gonadotropin's gland swash and The antibody of β subunit.
35. a kind of detection human chorionic gonadotropin's gland swashs and the kit of β subunit, including the coated luminous particle of first antibody, Mark the secondary antibody of substance markers, the photosensitive particulate of marker specific bond substance markers, which is characterized in that the kit makes Include the following steps: that (1) swashs gland containing human chorionic gonadotropin and the sample to be tested of β subunit carries out chemiluminescence immunoassay with method Reaction, exciting and record chemiluminescent first time and second reads, and by the difference between second and first time reading Amplification is denoted as A, and (2) are swashed according to gland containing human chorionic gonadotropin and the reading amplification twice of a known standard substance of β subunit A ' does critical value, (3) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested the amplification A read twice with it is critical Value is made comparisons, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than described face Dividing value, then the concentration of the sample to be tested is higher than the concentration of the known standard substance.
36. a kind of detection human chorionic gonadotropin's gland swashs and the kit of β subunit, including the coated luminous particle of first antibody, Mark the secondary antibody of substance markers, the photosensitive particulate of marker specific bond substance markers, which is characterized in that the kit makes Include the following steps: that (1) swashs gland containing human chorionic gonadotropin and the sample to be tested of β subunit carries out chemiluminescence immunoassay with method Reaction, exciting and record chemiluminescent first time and second reads, and by the difference between second and first time reading Amplification is denoted as A, and (2) are swashed according to gland containing human chorionic gonadotropin and the reading amplification twice of a known standard substance of β subunit A ' does critical value, (3) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested the amplification A read twice with it is critical Value is made comparisons, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than described face Dividing value, and the first time reading of the sample to be tested is lower than the known standard substance simultaneously, then after being diluted to sample again It is measured.
37. kit according to claim 35, which is characterized in that the application method of the kit includes following step It is rapid:
(a1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, label The secondary antibody of substance markers mixes, and incubates to obtain mixed liquor；
(a2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (a1), Exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(a3) it reads for second: after the reaction solution after progress first time reading in step (a2) is further incubated for, then carrying out Exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(a4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(a5) swashed according to gland containing human chorionic gonadotropin and the amplification of the reading twice A ' of a known standard substance of β subunit does and faces Dividing value；
(a6) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested the amplification A read twice and critical value make ratio Compared with, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the critical value, Then the concentration of the sample to be tested is higher than the concentration of the known standard substance.
38. kit according to claim 36, which is characterized in that the application method of the kit includes following step It is rapid:
(a1) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested and the coated luminous particle of first antibody, label The secondary antibody of substance markers mixes, and incubates to obtain mixed liquor；
(a2) it reads for the first time: adding the photosensitive particulate of marker specific bond substance markers in the mixed liquor of step (a1), Exciting light irradiation is carried out after incubation and detects transmitting light quantity, and photon counter reading is calculated as RLU1；
(a3) it reads for second: after the reaction solution after progress first time reading in step (a2) is further incubated for, then carrying out Exciting light irradiates and detects transmitting light quantity, and photon counter reading is calculated as RLU2；
(a4) it calculates second of sample and reads amplification A, A=that gained signal value reads gained signal value relative to first time (RLU2/RLU1-1) × 100%；
(a5) swashed according to gland containing human chorionic gonadotropin and the amplification of the reading twice A ' of a known standard substance of β subunit does and faces Dividing value；
(a6) by gland containing human chorionic gonadotropin swash and β subunit sample to be tested the amplification A read twice and critical value make ratio Compared with, if gland containing human chorionic gonadotropin swashs and the amplification A of the sample to be tested of β subunit read twice is greater than the critical value, And the first time reading gained signal value of the sample to be tested is then diluted sample lower than the known standard substance simultaneously It is measured again afterwards.
39. kit according to claim 35, which is characterized in that the known standard substance is positive control.
40. the kit according to claim 35 or 36, which is characterized in that luminous particle refers to filled with luminophor With the high molecular particle of lanthanide compound；The photosensitive particulate is filled with the high molecular particle of Photoactive compounds, red Under color laser excitation, singlet oxygen ion can produce.
41. the kit according to claim 35 or 36, which is characterized in that in step (a2) and (a3), with 600~ The red exciting light of 700nm irradiates, and detects the transmitting light quantity of reaction solution；The Detection wavelength for emitting light is 520~620nm.
42. the kit according to claim 35 or 36, which is characterized in that the antibody refers to capable of identifying for body generation The immunoglobulin of specific exotic；The first antibody and secondary antibody, which refer to, can specifically bind to the human chorionic gonadotropin Gland swashs and the antibody of β subunit.
CN201811401320.2A 2016-11-22 2016-11-22 Immunoassay method and system for human chorionic gonadotropin and beta subunit Active CN109470873B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811401320.2A CN109470873B (en) 2016-11-22 2016-11-22 Immunoassay method and system for human chorionic gonadotropin and beta subunit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811401320.2A CN109470873B (en) 2016-11-22 2016-11-22 Immunoassay method and system for human chorionic gonadotropin and beta subunit
CN201611026623.1A CN108152505B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201611026623.1A Division CN108152505B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay

Publications (2)

Publication Number Publication Date
CN109470873A true CN109470873A (en) 2019-03-15
CN109470873B CN109470873B (en) 2022-04-08

Family

ID=62469300

Family Applications (12)

Application Number Title Priority Date Filing Date
CN201811401321.7A Active CN109470865B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay
CN201811400033.XA Active CN109470856B (en) 2016-11-22 2016-11-22 Immunoassay method and system for carbohydrate antigen 125
CN201811401317.0A Active CN109470857B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay
CN201811401535.4A Active CN109470869B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay
CN201811400151.0A Withdrawn CN109470864A (en) 2016-11-22 2016-11-22 Method of immunity, the system for identifying immunoassays and kit
CN201811401541.XA Active CN109470870B (en) 2016-11-22 2016-11-22 Immunoassay method
CN201811401472.2A Active CN109470867B (en) 2016-11-22 2016-11-22 Immunoassay method and system for hepatitis B virus surface antibody
CN201811400051.8A Active CN109470863B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay
CN201811401545.8A Withdrawn CN109470871A (en) 2016-11-22 2016-11-22 Method of immunity, the system for identifying immunoassays and kit
CN201811401473.7A Active CN109470868B (en) 2016-11-22 2016-11-22 Immunoassay method and system for hepatitis C virus antibody
CN201811401320.2A Active CN109470873B (en) 2016-11-22 2016-11-22 Immunoassay method and system for human chorionic gonadotropin and beta subunit
CN201611026623.1A Active CN108152505B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay

Family Applications Before (10)

Application Number Title Priority Date Filing Date
CN201811401321.7A Active CN109470865B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay
CN201811400033.XA Active CN109470856B (en) 2016-11-22 2016-11-22 Immunoassay method and system for carbohydrate antigen 125
CN201811401317.0A Active CN109470857B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay
CN201811401535.4A Active CN109470869B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay
CN201811400151.0A Withdrawn CN109470864A (en) 2016-11-22 2016-11-22 Method of immunity, the system for identifying immunoassays and kit
CN201811401541.XA Active CN109470870B (en) 2016-11-22 2016-11-22 Immunoassay method
CN201811401472.2A Active CN109470867B (en) 2016-11-22 2016-11-22 Immunoassay method and system for hepatitis B virus surface antibody
CN201811400051.8A Active CN109470863B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay
CN201811401545.8A Withdrawn CN109470871A (en) 2016-11-22 2016-11-22 Method of immunity, the system for identifying immunoassays and kit
CN201811401473.7A Active CN109470868B (en) 2016-11-22 2016-11-22 Immunoassay method and system for hepatitis C virus antibody

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201611026623.1A Active CN108152505B (en) 2016-11-22 2016-11-22 Immunoassay method, system and kit for identifying immunoassay

Country Status (1)

Country Link
CN (12) CN109470865B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3798615B1 (en) * 2018-05-21 2023-12-20 Chemclin Diagnostics (Shanghai) Co., Ltd. Chemiluminescence analytical method and system and kit using same
CN110823869A (en) * 2018-08-10 2020-02-21 上海索昕生物科技有限公司 Light-activated chemiluminescence detection device
CN113125712B (en) * 2019-12-31 2023-06-16 科美博阳诊断技术(上海)有限公司 Homogeneous chemiluminescence detection kit for hepatitis C virus antibody and application thereof
CN113113079B (en) * 2021-02-25 2023-04-11 安徽桐康医疗科技股份有限公司 Method for identifying hook effect in quantitative immunochromatography test
CN115877012A (en) * 2021-09-27 2023-03-31 深圳市理邦精密仪器股份有限公司 Antigen concentration measuring method and measuring instrument
CN114594260A (en) * 2022-03-28 2022-06-07 河南中医药大学第一附属医院 Method for recognizing hook effect in HBsAg through light-activated chemiluminescence homogeneous immunoassay
CN116429754B (en) * 2023-02-13 2024-07-19 科美博阳诊断技术(上海)有限公司 HCV detection kit and using method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027234A1 (en) * 2001-07-30 2003-02-06 Pandian Murugan R. Methods for detecting Down's syndrome
US20050148096A1 (en) * 2004-01-07 2005-07-07 Cole Laurence A. Methods for detecting pregnancy
CN102338804A (en) * 2011-08-31 2012-02-01 内蒙古科慧生物科技有限责任公司 Quantitative determination kit for free human chorionic gonadotropin beta subunit (F-beta-HCG) and detection method thereof
CN102348980A (en) * 2009-03-12 2012-02-08 西门子医疗保健诊断公司 Immunoassays employing non-particulate chemiluminescent reagent
CN102749461A (en) * 2012-06-26 2012-10-24 博奥赛斯（天津）生物科技有限公司 Kit for chemiluminescent quantitative immunoassay of free beta-human chorionic gonadotrophin (hCG) and preparation method thereof
EP2790019A1 (en) * 2013-04-10 2014-10-15 Siemens Healthcare Diagnostics Products GmbH High dose hook detection

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2203836B (en) * 1987-04-24 1991-01-23 Dr Ch Ng Soo Ling Determination of analyte concentration by re-equilibration
EP0968425B1 (en) * 1996-12-03 2003-06-25 SOINI, Erkki Biospecific, two photon excitation, fluorescence detection and device
JP3920448B2 (en) * 1998-03-18 2007-05-30 オリンパス株式会社 Prozone phenomenon judgment method
JP2000221195A (en) * 1999-02-03 2000-08-11 Toshiba Iyo System Engineering Kk Prozone judging method, storage medium storing the same and automatic analyzer using the same
DE10064827A1 (en) * 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Sandwich assay for detecting analyte, useful e.g. for hormones, with detection or correction of the hook effect by measuring detection signals twice
US20030109067A1 (en) * 2001-12-06 2003-06-12 Immunetech, Inc. Homogeneous immunoassays for multiple allergens
US7851209B2 (en) * 2003-04-03 2010-12-14 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in assay devices
US7439079B2 (en) * 2005-04-29 2008-10-21 Kimberly-Clark Worldwide, Inc. Assay devices having detection capabilities within the hook effect region
CN100489528C (en) * 2005-06-17 2009-05-20 上海透景生命科技有限公司 Method for indicating high dose hook effect
EP1845373A1 (en) * 2006-04-13 2007-10-17 Olympus Life and Material Science Europa GmbH An immunoassay method
JP5553615B2 (en) * 2007-03-01 2014-07-16 アボット・ラボラトリーズ Immunoassay showing reduced prozone phenomenon
CN101251540B (en) * 2008-03-26 2012-12-05 博阳生物科技（上海）有限公司 Hepatitis B virus e antigen testing corpuscle, preparation and application thereof
WO2009126336A1 (en) * 2008-04-11 2009-10-15 Becton, Dickinson And Company Methods of controlling the sensitivity and dynamic range of a homogeneous assay
CN101281137A (en) * 2008-04-24 2008-10-08 博阳生物科技（上海）有限公司 Light activating chemical luminescence luminous immune detecting method
GB0809995D0 (en) * 2008-05-31 2008-07-09 Spd Swiss Prec Diagnostics Gmb Assay device
CN101620229B (en) * 2008-07-02 2013-04-17 博阳生物科技（上海）有限公司 Hepatits B virus e antibody assay kit and assay method thereof
CN101666801A (en) * 2008-09-02 2010-03-10 博阳生物科技（上海）有限公司 Hepatitis B virus surface antigen detection particles, preparation thereof and use thereof
CN101750487B (en) * 2008-12-02 2013-07-03 博阳生物科技（上海）有限公司 Dry method photic stimulation chemiluminescence immunoassay reagent kit and preparation and application thereof
CN101769929A (en) * 2008-12-30 2010-07-07 博阳生物科技（上海）有限公司 Surface antibody testing fine particles for hepatitis B virus, and preparation and application thereof
CN101769927B (en) * 2008-12-30 2014-06-18 博阳生物科技（上海）有限公司 Detection particle of carcino-embryonic antigen as well as preparation and application thereof
CN101769931B (en) * 2008-12-30 2013-10-02 博阳生物科技（上海）有限公司 Fetus alpha globulin detection particles, preparation thereof and application thereof
US20120220051A1 (en) * 2009-07-08 2012-08-30 Anp Technologies, Inc. Immunogenicity Assay
JP5714912B2 (en) * 2009-08-07 2015-05-07 アークレイ株式会社 Prozone phenomenon detection method, analysis method, prozone phenomenon detection device, and analysis device
CN102323419B (en) * 2011-08-31 2013-10-09 内蒙古科慧生物科技有限责任公司 Kit and detection method for quantitative determination of digoxin
CN102654501A (en) * 2012-05-21 2012-09-05 江苏省原子医学研究所 Method for detecting optically-excited chemiluminiscence of pepsinogen II and reagent kit
CN102944672B (en) * 2012-11-16 2015-05-20 李方和 Method for qualitatively and quantitatively detecting target substance to be detected in blood serum by utilizing light initiated chemiluminescence immune assay
CN103063845A (en) * 2012-12-18 2013-04-24 苏州浩欧博生物医药有限公司 Nanometer magnetic particle chemiluminiscence kit, preparation method and detection method of hepatitis B virus surface-antibody
CN103616510A (en) * 2013-12-06 2014-03-05 苏州长光华医生物医学工程有限公司 Hepatitis B surface antibody measurement kit and detection method thereof
CN103837675B (en) * 2014-03-07 2016-01-13 天津市南开医院 The homogeneous luminescent immune analysis method of polycomponent Simultaneous Quantitative Analysis and the kit used thereof
CN104730247A (en) * 2015-03-12 2015-06-24 广州市丰华生物工程有限公司 Kit suitable for rapidly detecting AMH and INHB by using double-tagging time resolution fluorescence immunoassay method and use method of kit
CN105044332B (en) * 2015-06-04 2017-10-10 天津起跑线生物信息技术有限公司 A kind of method for monitoring HOOK effects in immune colloid gold experiment
CN104991056B (en) * 2015-08-05 2017-01-04 武汉林勉生物技术有限公司 A kind of Serologic detection and the method for quantitative analysis
CN105785030A (en) * 2016-03-09 2016-07-20 博阳生物科技（上海）有限公司 Light-activating chemiluminescence immunoassay kit for serum specific IgE (immunoglobulin E)
CN105758835B (en) * 2016-05-04 2018-03-27 成都爱兴生物科技有限公司 A kind of homogeneous immunoassay POCT detection methods and the system using the detection method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027234A1 (en) * 2001-07-30 2003-02-06 Pandian Murugan R. Methods for detecting Down's syndrome
US20050148096A1 (en) * 2004-01-07 2005-07-07 Cole Laurence A. Methods for detecting pregnancy
CN102348980A (en) * 2009-03-12 2012-02-08 西门子医疗保健诊断公司 Immunoassays employing non-particulate chemiluminescent reagent
CN102338804A (en) * 2011-08-31 2012-02-01 内蒙古科慧生物科技有限责任公司 Quantitative determination kit for free human chorionic gonadotropin beta subunit (F-beta-HCG) and detection method thereof
CN102749461A (en) * 2012-06-26 2012-10-24 博奥赛斯（天津）生物科技有限公司 Kit for chemiluminescent quantitative immunoassay of free beta-human chorionic gonadotrophin (hCG) and preparation method thereof
EP2790019A1 (en) * 2013-04-10 2014-10-15 Siemens Healthcare Diagnostics Products GmbH High dose hook detection

Also Published As

Publication number Publication date
CN109470857B (en) 2021-12-17
CN109470868A (en) 2019-03-15
CN109470863A (en) 2019-03-15
CN108152505B (en) 2021-06-04
CN109470865A (en) 2019-03-15
CN109470856A (en) 2019-03-15
CN109470863B (en) 2021-12-17
CN109470867B (en) 2022-07-15
CN109470857A (en) 2019-03-15
CN109470870B (en) 2022-04-15
CN109470865B (en) 2022-04-15
CN109470869B (en) 2022-01-25
CN109470867A (en) 2019-03-15
CN109470873B (en) 2022-04-08
CN109470868B (en) 2022-04-15
CN109470856B (en) 2022-01-25
CN109470871A (en) 2019-03-15
CN109470870A (en) 2019-03-15
CN108152505A (en) 2018-06-12
CN109470869A (en) 2019-03-15
CN109470864A (en) 2019-03-15

Similar Documents

Publication Publication Date Title
CN109470873A (en) Method of immunity, the system for identifying immunoassays and kit
CN109470861A (en) Method of immunity, the system for identifying immunoassays and kit
CN101251540A (en) Hepatitis B virus e antigen testing corpuscle, preparation and application thereof
CN110514651A (en) A kind of chemiluminscence immunoassay method and the system using this method, kit
CN101620229A (en) Hepatits B virus e antibody assay kit and assay method thereof
CN107406510A (en) Prostate antigen standard items and application thereof
CN101666801A (en) Hepatitis B virus surface antigen detection particles, preparation thereof and use thereof
CN101769929A (en) Surface antibody testing fine particles for hepatitis B virus, and preparation and application thereof
CN108204959A (en) Differentiate the method for HD-HOOK effect samples and the system of the HD-HOOK effects in identification immunoassays
CN101769928A (en) Core antibody testing fine particles for hepatitis b virus, and preparation and application thereof
CN110514648A (en) A kind of chemiluminescence analysis POCT detection device and its application
CN109239357A (en) Type Ⅳ collagen chemiluminescence immune detection reagent kit and preparation method thereof and detection method
CN109298187A (en) A kind of chemiluminescence immunoassay method measuring c reactive protein
CN110514647A (en) A kind of chemiluminescence analysis measuring method and the system using this method, kit
CN110514646A (en) A kind of chemiluminescence analysis measuring method and the system using this method, kit
CN110514649A (en) A kind of chemiluminescence analysis POCT detection device and its application
CN110514650A (en) A kind of chemiluminescence analysis measuring method and the system using this method, kit

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 200131 third and fifth floors, building 1, No. 88 Cailun Road, pilot Free Trade Zone, Pudong New Area, Shanghai

Applicant after: Kemei Boyang diagnostic technology (Shanghai) Co., Ltd

Address before: 201210 east of the fifth floor, No. 88 Cailun Road, pilot Free Trade Zone, Pudong New Area, Shanghai

Applicant before: Boyang Biotechnology (Shanghai) Co., Ltd

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant